Fluticasone propionate nasal spray

DRUG4 trials

Sponsors

Palau Pharma S.L.U., ORA, Inc., Meda Pharmaceuticals, Pamukkale University

Conditions

Allergic ConjunctivitisAllergic RhinitisSeasonal Allergic Rhinitis

Phase 2

Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

CompletedNCT01260753

Palau Pharma S.L.U.Seasonal Allergic Rhinitis

Start: 2010-12-31End: 2011-03-31Target: 24Updated: 2011-04-15

Phase 3

3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis

CompletedNCT01794741

Meda PharmaceuticalsAllergic Rhinitis

Start: 2013-02-28Updated: 2015-03-31

Phase 4

An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo

CompletedNCT01439815

ORA, Inc.Allergic Conjunctivitis, Allergic Rhinitis

Start: 2011-09-30End: 2011-10-31Updated: 2021-04-14

INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION

Active, not recruitingNCT07415278

Pamukkale UniversityAllergic Rhinitis

Start: 2022-12-01End: 2026-10-30Updated: 2026-02-17

Related Papers

Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial

Allergy and Asthma Proceedings2018-03-0126 citations